Zosano Pharma Corp Operating Expenses
Zosano Pharma Corp reported Operating Expenses of $8.53 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-11-13
- Zosano Pharma Corp operating expenses for the quarter ending 2020-09-30 was $8.53M, a 10.77% decline year-over-year.
- Zosano Pharma Corp operating expenses for the quarter ending 2020-06-30 was $7.70M, a 18.17% decline year-over-year.
- Zosano Pharma Corp operating expenses for the quarter ending 2020-03-31 was $8.60M, a 9.39% decline year-over-year.
- Zosano Pharma Corp operating expenses for the quarter ending 2019-12-31 was $8.75M, a 14.68% decline year-over-year.
- Zosano Pharma Corp operating expenses for fiscal 2019 was $37.20M, a 5.15% increase from fiscal 2018.
- Zosano Pharma Corp operating expenses for fiscal 2018 was $35.38M, a 24.70% increase from fiscal 2017.
- Zosano Pharma Corp operating expenses for fiscal 2017 was $28.37M, a 0.92% decline from fiscal 2016.
- Zosano Pharma Corp operating expenses for fiscal 2016 was $28.63M, a 7.32% increase from fiscal 2015.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2020-09-30 | $8.53M 10-Q · filed 2020-11-13 | $16.23M derived: sum of 2 quarters · filed 2020-11-13 | $24.82M 10-Q · filed 2020-11-13 | $33.57M derived: sum of 4 quarters · filed 2020-11-13 |
| 2020-06-30 | $7.70M 10-Q · filed 2020-08-06 | $16.29M 10-Q · filed 2020-08-06 | $25.04M derived: sum of 3 quarters · filed 2020-08-06 | $34.60M derived: sum of 4 quarters · filed 2020-11-13 |
| 2020-03-31 | $8.60M 10-Q · filed 2020-05-14 | $17.34M derived: sum of 2 quarters · filed 2020-05-14 | $26.90M derived: sum of 3 quarters · filed 2020-11-13 | $36.31M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-12-31 | $8.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $18.30M derived: sum of 2 quarters · filed 2020-11-13 | $27.71M derived: sum of 3 quarters · filed 2020-11-13 | $37.20M 10-K · filed 2020-03-13 |
| 2019-09-30 | $9.56M 10-Q · filed 2020-11-13 | $18.96M derived: sum of 2 quarters · filed 2020-11-13 | $28.45M 10-Q · filed 2020-11-13 | $38.70M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $9.41M 10-Q · filed 2020-08-06 | $18.89M 10-Q · filed 2020-08-06 | $29.14M derived: sum of 3 quarters · filed 2020-08-06 | $37.40M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $9.49M 10-Q · filed 2020-05-14 | $19.74M derived: sum of 2 quarters · filed 2020-05-14 | $27.99M derived: sum of 3 quarters · filed 2020-05-14 | $36.80M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $10.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $18.50M derived: sum of 2 quarters · filed 2020-03-13 | $27.31M derived: sum of 3 quarters · filed 2020-03-13 | $35.38M 10-K · filed 2020-03-13 |
| 2018-09-30 | $8.25M 10-Q · filed 2019-11-14 | $17.06M derived: sum of 2 quarters · filed 2019-11-14 | $25.13M 10-Q · filed 2019-11-14 | $32.48M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $8.80M 10-Q · filed 2019-08-14 | $16.87M 10-Q · filed 2019-08-14 | $24.22M derived: sum of 3 quarters · filed 2019-08-14 | $31.94M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $8.07M 10-Q · filed 2019-05-14 | $15.42M derived: sum of 2 quarters · filed 2019-05-14 | $23.14M derived: sum of 3 quarters · filed 2019-05-14 | $29.69M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $7.35M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $15.07M derived: sum of 2 quarters · filed 2019-03-25 | $21.62M derived: sum of 3 quarters · filed 2019-03-25 | $28.37M 10-K · filed 2019-03-25 |
| 2017-09-30 | $7.72M 10-Q · filed 2018-11-15 | $14.27M derived: sum of 2 quarters · filed 2018-11-15 | $21.02M 10-Q · filed 2018-11-15 | $28.47M derived: sum of 4 quarters · filed 2018-11-15 |
| 2017-06-30 | $6.55M 10-Q · filed 2017-08-10 | $13.30M 10-Q · filed 2018-08-09 | $20.75M derived: sum of 3 quarters · filed 2018-08-09 | $27.89M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $6.75M 10-Q · filed 2018-05-15 | $14.20M derived: sum of 2 quarters · filed 2018-05-15 | $21.33M derived: sum of 3 quarters · filed 2018-05-15 | $27.58M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $14.59M derived: sum of 2 quarters · filed 2018-03-12 | $20.84M derived: sum of 3 quarters · filed 2018-03-12 | $28.63M 10-K · filed 2018-03-12 |
| 2016-09-30 | $7.13M 10-Q · filed 2017-11-09 | $13.38M derived: sum of 2 quarters · filed 2017-11-09 | $21.18M 10-Q · filed 2017-11-09 | $28.36M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $6.25M 10-Q · filed 2017-08-10 | $14.05M 10-Q · filed 2017-08-10 | $21.23M derived: sum of 3 quarters · filed 2017-08-10 | $29.58M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $7.80M 10-Q · filed 2017-05-09 | $14.98M derived: sum of 2 quarters · filed 2017-05-09 | $23.33M derived: sum of 3 quarters · filed 2017-05-09 | $30.11M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $15.53M derived: sum of 2 quarters · filed 2017-03-01 | $22.31M derived: sum of 3 quarters · filed 2017-03-01 | $26.68M 10-K · filed 2017-03-01 |
| 2015-09-30 | $8.35M 10-Q · filed 2016-11-09 | $15.13M derived: sum of 2 quarters · filed 2016-11-09 | $19.50M 10-Q · filed 2016-11-09 | $23.43M derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-06-30 | $6.78M 10-Q · filed 2016-08-10 | $11.15M 10-Q · filed 2016-08-10 | $15.09M derived: sum of 3 quarters · filed 2016-08-10 | $18.57M derived: sum of 4 quarters · filed 2016-08-10 |
| 2015-03-31 | $4.37M 10-Q · filed 2016-05-12 | $8.30M derived: sum of 2 quarters · filed 2016-05-12 | $11.79M derived: sum of 3 quarters · filed 2016-05-12 | $15.67M derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $7.42M derived: sum of 2 quarters · filed 2016-03-29 | $11.30M derived: sum of 3 quarters · filed 2016-03-29 | $15.47M 10-K · filed 2016-03-29 |
| 2014-09-30 | $3.48M 10-Q · filed 2015-11-10 | $7.37M derived: sum of 2 quarters · filed 2015-11-10 | $11.54M 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $3.89M 10-Q · filed 2015-08-13 | $8.06M 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $4.17M 10-Q · filed 2015-05-12 |